Citius Pharmaceuticals (CTXR) Treasury Shares (2022)
Citius Pharmaceuticals' (CTXR) quarterly Treasury Shares came in at $35000.0 in Q4 2022.
Powered by 
Analysis
Citius Pharmaceuticals (CTXR) Treasury Shares (2022) Analysis & Trends
Citius Pharmaceuticals (CTXR) has reported Treasury Shares for 1 consecutive years, with $35000.0 the latest figure, recorded in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 640.32 Bn | 619.56 Bn | 17.26 Bn | 711.62 Mn |
| 2 | AbbVie | 445.20 Bn | 438.64 Bn | 12.70 Bn | 77.11 Mn |
| 3 | Merck | 357.17 Bn | 350.03 Bn | 12.21 Bn | 64.13 Bn |
| 4 | Novartis Ag | 267.38 Bn | 259.69 Bn | 11.24 Bn | -49.00 Mn |
| 5 | Pfizer | 156.69 Bn | 145.00 Bn | 10.94 Bn | 3.94 Bn |
| 6 | Sanofi | 52.12 Bn | 44.74 Bn | 10.79 Bn | - |
| 7 | Revolution Medicines | 42.92 Bn | 42.92 Bn | - | - |
| 8 | Incyte | 24.60 Bn | 20.06 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.29 Bn | 18.63 Bn | 683.80 Mn | 35.35 Mn |
| 10 | Citius Pharmaceuticals | 15.47 Mn | 15.47 Mn | 1.00 Mn | - |